本文已被：浏览 3514次 下载 0次
中文摘要: 赵建刚①,靳素琴①#,胡云霞②
摘要 通过收集中国境内2003年严重急性呼吸综合症（SARS）和2020年1—3月新型冠状病毒肺炎（COVID-19）疫情信息，对这两种疾病从病原学、临床症状、流行特征和中医药诊治效果等方面进行了分析。2003年SARS在我国境内共累计确诊5 327例，报告死亡病例349例，病死率约为7%；2019年COVID-19在中国境内截止2020年3月31日共累计确诊81 554例，报告死亡病例3 312例，病死率约为4%，由此看出，尽管两种病毒同属于SARS相关冠状病毒，但2019年COVID-19的确诊人数远远多于SARS，但其死亡率却小于后者，究其原因可能与两种病毒的传染性、致病力和人员流动性等因素有关。
Abstract:Abstract The epidemic information of severe acute respiratory syndrome (SARS) in 2003 and novel coronavirus (COVID-19) in 2019 from January to March 2020 in China were collected to analyze the pathogens, clinical symptoms, epidemic characteristics and therapeutic effects of traditional Chinese medicine. A total of 5 327 cases were confirmed in China in SARS, 349 deaths were reported, the case fatality rate was about 7%. 81 554 cases of COVID-19 were confirmed in China, about 3 312 deaths were reported, and the case fatality rate was about 4%. Although both viruses belong to SARS-related coronavirus，but the COVID-19 was far larger in terms of confirmed cases than the SARS, but the case fatality rate was lower than the latter. The reasons could be related to the infectivity and pathogenicity of the two types of virus and the mobility of people.
文章编号：3202005117 中图分类号：R52 文献标志码：
基金项目:
| 作者 | 单位 |
| 赵建刚①,靳素琴①#,胡云霞② |
| Author Name | Affiliation |
引用文本：